Premedications Prior to Irinotecan
Administer antiemetic premedication with dexamethasone 10 mg plus a 5-HT3 receptor antagonist (ondansetron or granisetron) starting at least 30 minutes before irinotecan infusion. 1
Antiemetic Prophylaxis
The FDA label explicitly recommends premedication with antiemetic agents for all patients receiving irinotecan 1. Based on clinical trial data:
- Dexamethasone 10 mg given in conjunction with a 5-HT3 blocker
- 5-HT3 antagonists: ondansetron or granisetron
- Timing: Start at least 30 minutes before irinotecan administration
- Additional coverage: Provide patients with a take-home antiemetic regimen (e.g., prochlorperazine) for subsequent use as needed 1
The ESMO guidelines classify irinotecan-containing regimens as moderate to high emetogenic risk, with FOLFIRI causing grade 3-4 diarrhea in 14% of patients and CapeIRI in 47% 2. This supports the need for robust antiemetic prophylaxis.
Anticholinergic Prophylaxis for Acute Diarrhea
Consider prophylactic atropine 0.5 mg subcutaneously for patients at risk of acute cholinergic syndrome. 1
Irinotecan causes two distinct types of diarrhea:
Acute (Early-Onset) Diarrhea
- Occurs during or immediately after infusion
- Caused by cholinergic properties
- Accompanied by: abdominal cramping, rhinitis, lacrimation, salivation, diaphoresis, flushing, bradycardia 2
- Management: Atropine 0.25-1 mg subcutaneously or IV responds rapidly (mean symptom duration 30 minutes) 2
- Prophylaxis: Premedication with atropine 0.5 mg SC may prevent acute diarrhea 2
Delayed-Onset Diarrhea
- Occurs ≥24 hours after administration
- Potentially life-threatening, especially with combination regimens
- Critical: Ensure patients have loperamide at home before leaving the infusion center 1
Additional Premedication Considerations
UGT1A1 Genotype-Specific Dosing
If UGT1A1 testing reveals homozygous *28/*28, *6/*6, or compound heterozygous *6/*28 genotypes, reduce the starting irinotecan dose by at least one dose level 1. This reduces severe neutropenia and diarrhea risk without requiring additional premedications, but emphasizes the importance of having antiemetics and loperamide readily available.
Patient Education Before First Dose
Provide patients with:
- Loperamide to take home with specific instructions: 4 mg at first loose stool, then 2 mg every 2 hours until diarrhea-free for 12 hours 1
- Instructions to contact physician immediately if: diarrhea persists >24 hours, black/bloody stools, signs of dehydration, fever, or inability to control diarrhea 1
- Warning about potential dizziness/visual disturbances within 24 hours post-infusion 1
Common Pitfalls to Avoid
- Do not skip antiemetic premedication even if the patient tolerated previous cycles well—nausea/vomiting can be cumulative
- Do not wait for acute cholinergic symptoms to develop before considering atropine; prophylactic use is appropriate for high-risk patients 2
- Do not send patients home without loperamide and clear instructions—delayed diarrhea is the primary dose-limiting toxicity 2
- Do not use standard antiemetic dosing if combining with aprepitant; reduce dexamethasone dose to 50% when used with aprepitant due to CYP3A4 interactions 3